Olema Pharmaceuticals reported cash from operations of -$45.90M and free cash flow of -$45.90M for the quarter ended Jun 2026, down 53.6% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -17.66M | -21.65M | -23.04M | -32.88M | -22.60M | -26.25M | -28.30M | -20.05M | -21.42M | -26.86M | -30.99M | -30.42M | -34.69M | -33.47M | -30.35M | -43.82M | -42.23M | -46.07M | -53.21M | -62.67M | ||||||
| Share-based Compensation | 5.56M | 4.63M | 8.37M | 8.43M | 8.33M | 4.86M | 9.84M | 9.28M | 8.98M | 4.35M | 10.79M | 11.22M | 11.37M | 6.32M | 14.64M | 15.17M | 15.49M | 4.27M | 17.05M | 17.87M | ||||||
| Cash from Operations | -12.10M | -18.60M | -17.90M | -26.46M | -17.99M | -19.71M | -20.39M | -22.12M | -22.74M | -18.48M | -23.50M | -27.55M | -27.02M | -26.28M | -43.98M | -29.88M | -34.53M | -38.33M | -45.99M | -45.90M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of Intangibles | -0.08M | 1.44M | 0.32M | 0.33M | 0.33M | 0.33M | 0.33M | 0.33M | 0.32M | 0.32M | 0.29M | 0.29M | 0.29M | -9.04M | 0.29M | 0.29M | 0.30M | -7.17M | 0.30M | 0.30M | ||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.05M | 0.07M | 0.08M | 0.09M | 0.09M | 0.10M | 0.10M | 0.10M | 0.09M | 0.09M | 0.09M | 0.09M | 0.10M | 0.12M | 0.13M | 0.13M | 0.04M | 0.19M | 0.12M | 0.10M | ||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Account Payables | -0.20M | -0.16M | 0.24M | -0.15M | -0.11M | 0.36M | 0.31M | 0.94M | 0.58M | 0.49M | 4.96M | -3.30M | -1.67M | 2.52M | -4.31M | 0.74M | 2.39M | 5.77M | -5.68M | -1.91M | ||||||
| Change in Accured Expenses | 1.18M | -0.50M | -0.11M | 2.03M | 1.37M | 3.74M | 2.69M | -5.38M | 0.47M | 5.17M | -0.40M | 3.56M | 5.82M | 2.23M | -11.25M | 12.70M | 5.90M | 3.63M | 1.30M | 8.03M | ||||||
| Other Working Capital Changes | -0.35M | 0.24M | -0.32M | -0.32M | -0.32M | 2.91M | -1.03M | 0.38M | -0.32M | -0.26M | -1.59M | -0.03M | 0.15M | 0.31M | -0.55M | 1.86M | -0.35M | 4.46M | -2.60M | -0.07M | ||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital Expenditures | 0.10M | 0.70M | 0.03M | 0.02M | 0.14M | 0.17M | 0.15M | 0.01M | ||||||||||||||||||
| Change in Acquisitions & Divestments | 119.45M | 26.66M | 148.75M | 57.00M | 38.75M | 61.00M | 61.76M | 64.50M | 70.50M | 54.00M | 56.10M | 77.29M | 93.39M | 74.81M | 97.77M | 67.10M | 88.92M | 91.17M | 74.47M | 89.30M | ||||||
| Cash from Investing Activities | -12.78M | 6.00M | 25.57M | 29.41M | 20.16M | 16.34M | 37.39M | 14.11M | -25.44M | -30.91M | -20.14M | -4.88M | 45.92M | -114.42M | -45.08M | 34.23M | 17.27M | -162.18M | 4.53M | 40.84M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activities | 0.06M | 0.48M | 0.03M | 0.01M | 0.11M | 0.22M | 1.33M | 128.21M | -0.02M | 0.92M | 0.07M | 0.09M | 242.42M | 0.24M | 0.23M | 0.04M | 7.88M | 8.43M | -4.19M | |||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||
| Long-Term Debt Issuances | ||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 1.30M | 2.66M | 3.29M | 1.99M | 2.57M | 2.53M | 3.48M | 3.49M | 5.03M | 3.50M | ||||||||||||||||
| Net Equity Issued and Repurchased | 7.90M | 14.90M | ||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||
| Cash from Financing Activities | 0.06M | 0.82M | 0.03M | 0.06M | 0.11M | 0.27M | 0.22M | 2.04M | 130.63M | 0.52M | 8.82M | 15.61M | 0.09M | 244.30M | 0.22M | -2.52M | 0.04M | 213.55M | 45.70M | 1.11M | ||||||
| Change in Cash | -24.82M | -11.79M | 7.70M | 3.02M | 2.28M | -3.10M | 17.22M | -5.96M | 82.45M | -48.87M | -34.82M | -16.83M | 19.00M | 103.59M | -88.84M | 1.83M | -17.21M | 13.04M | 4.25M | -3.95M | ||||||
| Free Cash Flow | -12.19M | -19.30M | -17.93M | -26.48M | -18.13M | -19.88M | -20.39M | -22.12M | -22.74M | -18.48M | -23.65M | -27.56M | -27.02M | -26.28M | -43.98M | -29.88M | -34.53M | -38.33M | -45.99M | -45.90M | ||||||
| Net Cash Flow | -24.82M | -11.79M | 7.70M | 3.02M | 2.28M | -3.10M | 17.22M | -5.96M | 82.45M | -48.87M | -34.82M | -16.83M | 19.00M | 103.59M | -88.84M | 1.83M | -17.21M | 13.04M | 4.25M | -3.95M |